<p num="1"><br/><br/>The synthesis and activity of novel LpxA inhibitors is described. The <br/>compounds were designed based on a receptor model developed using the <br/>crystal structure of LpxA and are arranged to have a favorable binding <br/>interaction <br/>at the active site of the enzyme.<br/>